Prevention of Varicella by Zoster Immune Globulin
- 29 May 1969
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 280 (22) , 1191-1194
- https://doi.org/10.1056/nejm196905292802201
Abstract
Zoster immune globulin (ZIG) was found, in a double-blind study, to prevent varicella if a 2-ml dose was given to susceptible children within 72 hours of household exposure. Chicken pox developed in each of six households in the child who received human immune serum globulin, whereas no clinical manifestations appeared in his sibling who received ZIG. Moreover, none of the ZIG recipients had a rise in Varicella Zoster (V-Z) serum antibody after exposure, suggesting that infection had been prevented rather than modified. ZIG was prepared from plasma of patients convalescing from herpes zoster who had a V-Z complement-fixing antibody titer of 1:256 or higher. It may be useful in the prevention of varicella in children with cancer, children who are receiving steroid or antimetabolite therapy, newborn infants and susceptible adults.Keywords
This publication has 15 references indexed in Scilit:
- Varicella-zoster infections in pregnancyJAMA, 1967
- PERINATAL VARICELLAThe Lancet, 1965
- Modification of Chicken Pox in Family Contacts by Administration of Gamma GlobulinNew England Journal of Medicine, 1962
- Chickenpox and leukemiaThe Journal of Pediatrics, 1961
- THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTERThe Journal of Experimental Medicine, 1958
- THE NATURAL HISTORY OF HERPES ZOSTERJAMA, 1957
- A study of herpes zoster particularly in its relationship to chickenpoxEpidemiology and Infection, 1949
- Failure of gamma globulin to prevent varicellaThe Journal of Pediatrics, 1948
- The use of serum gamma globulin antibodies tocontrol chicken pox in a convalescent hospital for childrenThe Journal of Pediatrics, 1948
- Varicella and Herpes Zoster: An ExperimentBMJ, 1944